Epilepsy Drug Market
According to Intent Market Research, the Epilepsy Drug Market is expected to grow from USD 9.3 billion in 2023 at a CAGR of 5.2% to touch USD 13.2 billion by 2030. The Epilepsy Drug Market is dominated by key players such as Pfizer Inc., GlaxoSmithKline (GSK), Johnson & Johnson, Novartis AG, UCB Pharma, Eisai Co., Ltd., Abbott Laboratories, Sanofi, Merck & Co., Inc., Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Zogenix, Inc., LivaNova.